Toward Therapies Tailored to Patient Characteristics

This publication has 12 references indexed in Scilit:

• Prospective Assessment of XPD Lys751Gln and XRCC1 Arg399Gln Single Nucleotide Polymorphisms in Lung Cancer
  Clinical Cancer Research, 2007
• DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy
  New England Journal of Medicine, 2006
• ERCC1 mRNA-based randomized phase III trial of docetaxel (doc) doublets with cisplatin (cis) or gemcitabine (gem) in stage IV non-small-cell lung cancer (NSCLC) patients (p)
  Journal of Clinical Oncology, 2005
• Molecular Mechanisms of Radiotherapy
  Published by Wiley ,2005
• Hallmarks of 'BRCAness' in sporadic cancers
  Nature Reviews Cancer, 2004
• BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer
  Human Molecular Genetics, 2004
• Validation of RRM1 and PTEN as prognostic parameters of outcome in non-small cell lung cancer
  Journal of Clinical Oncology, 2004
• An Increase in the Expression of Ribonucleotide Reductase Large Subunit 1 Is Associated with Gemcitabine Resistance in Non-Small Cell Lung Cancer Cell Lines
  Cancer Research, 2004
• ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.
  Journal of Clinical Oncology, 1998
• Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells
  Proceedings of the National Academy of Sciences, 1997